The Pandemic All-Hazards Preparedness Reauthorization Act is up for renewal this year, and drugmakers are already lining up with their hands out. In other pharmaceutical news: a judge rules that Martin Shkreli can be held responsible for $10.4 million in losses related to his tenure at Turing Pharmaceuticals; an analysis finds oversight of compounding pharmacies improved; and a tweet sends one biotech company's stocks soaring.

from Kaiser Health News http://ift.tt/2oAKwVH

Related Posts:

0 comments:

Post a Comment

Popular Posts